Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atock Dry Syrup vs tulobuterol patch in acute bronchitis in children
NCT06411925Phase 4Recruiting
- Sponsor
- Sam-A Pharm
- Start
- Nov 2023
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of formoterol in acute bronchitis (2 arms), sponsored by Sam-A Pharm. Primary endpoint: Rate of subjects whose symptoms improved based on wheezing score at 3 days. Started Nov 2023; status: recruiting.
02
Drugs
formoterol
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on NCT06411925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06411925.